View in EDS HTML Full Text PDF Full Text

Nonviral delivery systems for antisense oligonucleotide therapeutics.

Saved in:
Bibliographic Details
Title: Nonviral delivery systems for antisense oligonucleotide therapeutics.
Authors: Huang S; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China., Hao XY; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China., Li YJ; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China., Wu JY; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China., Xiang DX; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China., Luo S; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China. Shilin_luo@csu.edu.cn.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China. Shilin_luo@csu.edu.cn.; Institute of Clinical Pharmacy, Central South University, Changsha, China. Shilin_luo@csu.edu.cn.
Source: Biomaterials research [Biomater Res] 2022 Sep 30; Vol. 26 (1), pp. 49. Date of Electronic Publication: 2022 Sep 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: AAAS Science Partner Journals Country of Publication: United States NLM ID: 101650636 Publication Model: Electronic Cited Medium: Print ISSN: 1226-4601 (Print) Linking ISSN: 12264601 NLM ISO Abbreviation: Biomater Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36180936
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nonviral delivery systems for antisense oligonucleotide therapeutics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+S%22">Huang S</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Hao+XY%22">Hao XY</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Li+YJ%22">Li YJ</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Wu+JY%22">Wu JY</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Xiang+DX%22">Xiang DX</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.; Institute of Clinical Pharmacy, Central South University, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Luo+S%22">Luo S</searchLink>; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China. Shilin_luo@csu.edu.cn.; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China. Shilin_luo@csu.edu.cn.; Institute of Clinical Pharmacy, Central South University, Changsha, China. Shilin_luo@csu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101650636%22">Biomaterials research</searchLink> [Biomater Res] 2022 Sep 30; Vol. 26 (1), pp. 49. <i>Date of Electronic Publication: </i>2022 Sep 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AAAS+Science+Partner+Journals%22">AAAS Science Partner Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101650636 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1226-4601 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2212264601%22">12264601 </searchLink><i>NLM ISO Abbreviation: </i>Biomater Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36180936
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40824-022-00292-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 49
    Titles:
      – TitleFull: Nonviral delivery systems for antisense oligonucleotide therapeutics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang S
      – PersonEntity:
          Name:
            NameFull: Hao XY
      – PersonEntity:
          Name:
            NameFull: Li YJ
      – PersonEntity:
          Name:
            NameFull: Wu JY
      – PersonEntity:
          Name:
            NameFull: Xiang DX
      – PersonEntity:
          Name:
            NameFull: Luo S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 09
              Text: 2022 Sep 30
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1226-4601
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Biomaterials research
              Type: main
ResultId 1